Press-release for stocks related to merge for pfizer, inc.

| -49.7% | O: 0.56% H: 0.0% C: 0.0%
SNY | News | $47.36 0.45% 120K

| -10.04% | O: 0.82% H: 0.0% C: 0.0%
BNTX | News | $89.07 1.2% 44K

| -39.32% | O: 1.63% H: 11.55% C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization

Investor Alert: The M&A Class Action Firm Continues Investigating the Merger - VG, TACO, ARNA, UMPQ, LEVL, NES
Published: 2022-01-15 (Crawled : 08:20) - prnewswire.com
BOX 4 | $27.345 0.83% 84K

Technology Services

| Email alert Add to watchlist
COLB I | $19.05 1.38% 220K

| Email alert Add to watchlist
WTTR | News | $9.27 140K

Industrial Services

| Email alert Add to watchlist
PFE | News A | $26.375 0.44% 1.9M

| Email alert Add to watchlist
ERIC | News | $5.31 0.95% 5.1M

Electronic Technology

| Email alert Add to watchlist
VG | $20.99 0.0%

| Email alert Add to watchlist
merge

Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
Published: 2022-01-14 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 3.7K

| 18.37% | O: -0.21% H: 0.98% C: 0.98%
PFE | News A | $26.375 0.44% 1.9M

| -52.72% | O: -1.01% H: 0.0% C: 0.0%
ONCY | $1.045 -3.24% -3.35% 180K

| -28.57% | O: 0.65% H: 0.0% C: 0.0%
INCY | $51.98 0.12% 72K

| -29.5% | O: 0.0% H: 0.0% C: 0.0%
AZN | News | $70.47 0.49% 990K

| 20.71% | O: 0.17% H: 0.0% C: 0.0%
treatment cancer breast cancer merge

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Published: 2022-01-03 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 600K

| -6.36% | O: -0.47% H: 0.0% C: 0.0%
PFE | News A | $26.375 0.44% 1.9M

| -55.53% | O: -0.93% H: 0.09% C: -3.16%
SNY | News | $47.36 0.45% 120K

| -7.63% | O: 1.16% H: 0.0% C: 0.0%
BNTX | News | $89.07 1.2% 44K

| -65.86% | O: -1.52% H: 0.89% C: -8.67%
covid-19 fda als covid authorization vaccine merge order emergency use authorization

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment
Published: 2021-12-22 (Crawled : 20:00) - biospace.com/
PFE | News A | $26.375 0.44% 1.9M

| -55.45% | O: 0.51% H: 2.25% C: 0.51%
covid-19 treatment fda covid authorization antiviral merge emergency use authorization

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Published: 2021-12-09 (Crawled : 18:00) - globenewswire.com
FNCTF | News | $11.16 130

| 9.3% | O: 0.69% H: 0.68% C: 0.68%
PFE | News A | $26.375 0.44% 1.9M

| -48.91% | O: 0.23% H: 0.0% C: 0.0%
SNY | News | $47.36 0.45% 120K

| -3.93% | O: -0.85% H: 0.0% C: 0.0%
BNTX | News | $89.07 1.2% 44K

| -71.51% | O: -3.53% H: 0.32% C: -4.65%
covid-19 fda covid authorization vaccine merge order emergency use authorization

Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
FNCTF | News | $11.16 130

| -0.53% | O: -2.67% H: 0.45% C: 0.45%
SNYNF | News | $92.7 600K

| -5.6% | O: 3.28% H: 0.0% C: 0.0%
PFE | News A | $26.375 0.44% 1.9M

| -48.92% | O: 0.84% H: 0.0% C: 0.0%
SNY | News | $47.36 0.45% 120K

| -7.76% | O: 0.4% H: 0.0% C: 0.0%
BNTX | News | $89.07 1.2% 44K

| -67.89% | O: 1.58% H: 0.0% C: 0.0%
covid fda vaccine merge order emergency use authorization

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Published: 2021-10-29 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
PFE | News A | $26.375 0.44% 1.9M

| Email alert Add to watchlist
SNY | News | $47.36 0.45% 120K

| Email alert Add to watchlist
FNCTF | News | $11.16 130

| Email alert Add to watchlist
BNTX | News | $89.07 1.2% 44K

| Email alert Add to watchlist
covid fda children vaccine merge emergency use authorization

FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE | News A | $26.375 0.44% 1.9M

| -39.34% | O: 0.39% H: 0.23% C: -1.13%
SNY | News | $47.36 0.45% 120K

| -6.78% | O: 0.91% H: 0.06% C: -1.04%
BNTX | News | $89.07 1.2% 44K

| -70.24% | O: -0.4% H: 1.16% C: -5.35%
covid fda children vaccine merge emergency use authorization

FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
Published: 2021-09-18 (Crawled : 08:20) - globenewswire.com
SNY | News | $47.36 0.45% 120K

| Email alert Add to watchlist
PFE | News A | $26.375 0.44% 1.9M

| Email alert Add to watchlist
BNTX | News | $89.07 1.2% 44K

| Email alert Add to watchlist
fda risk merge comirnaty® order

Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Published: 2021-08-13 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.375 0.44% 1.9M

| -44.41% | O: 0.55% H: 0.0% C: 0.0%
MYOV | $26.98 -0.04% 0.0% 0

| 22.25% | O: 0.27% H: 0.0% C: 0.0%
MS | News | $92.565 0.52% 310K

| -12.02% | O: -0.11% H: 0.0% C: 0.0%
JNJ | News | $148.88 -0.16% 940K

| -14.89% | O: -0.09% H: 0.0% C: 0.0%
F | News | $12.895 0.12% 15M

Consumer Durables

| -7.34% | O: 0.04% H: 0.0% C: 0.0%
CS | $0.8858 1.49% 64M

| -91.51% | O: -0.34% H: 0.0% C: 0.0%
EXAS | $64.41 3.21% 140K

| -35.21% | O: 1.64% H: 0.0% C: 0.0%
DMTK 4 | $0.621 4.25% 41K

| -98.39% | O: 0.86% H: 0.0% C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M

| -93.19% | O: -0.94% H: 0.0% C: 0.0%
merge

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Published: 2021-05-11 (Crawled : 07:00) - globenewswire.com
PFE | News A | $26.375 0.44% 1.9M

| -34.12% | O: -0.45% H: 0.98% C: -0.83%
SNY | News | $47.36 0.45% 120K

| -11.77% | O: -1.47% H: 0.7% C: 0.52%
BNTX | News | $89.07 1.2% 44K

| -56.51% | O: -7.78% H: 8.52% C: 6.11%
covid vaccine merge authorized covid-19

Global Active Pharmaceutical Ingredient (API) Market Report 2021-2025: Opportunities in Advancements in API Manufacturing, Growth in the CMOs, & Emergence of Biosimilars Market
Published: 2021-05-10 (Crawled : 12:15) - prnewswire.com
VTRS | News A | $11.3 0.44% 570K

| -20.1% | O: 6.39% H: 3.3% C: 0.4%
PFE | News A | $26.375 0.44% 1.9M

| -33.65% | O: 0.63% H: 1.13% C: 0.08%
NVS | News | $98.17 3.21% 780K

| 7.74% | O: 0.05% H: 0.37% C: -0.02%
GSK | News | $40.865 0.68% 320K

| 5.84% | O: 0.76% H: 0.27% C: -0.28%
LLY | News | $735.9 0.63% 180K

| 274.23% | O: 0.38% H: 0.22% C: -0.72%
BMY | $49.28 0.29% 800K

| -23.74% | O: 0.31% H: 1.01% C: 0.09%
ALB | News | $115.01 2.42% 280K

Process Industries

| -30.99% | O: 0.41% H: 1.07% C: -2.39%
SNY | News | $47.36 0.45% 120K

| -10.7% | O: 1.54% H: 0.17% C: -0.32%
cmo growth merge biosimilar

Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE | News A | $26.375 0.44% 1.9M

| -23.64% | O: 0.26% H: 1.13% C: -0.38%
NVS | News | $98.17 3.21% 780K

| 12.81% | O: -0.02% H: 0.89% C: -0.31%
ORGO | $2.985 0.51% 26K

| -80.32% | O: 1.86% H: 1.82% C: -2.21%
AMGN | News | $272.245 0.12% 220K

| 19.4% | O: 0.15% H: 1.81% C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Published: 2020-12-10 (Crawled : 00:01) - globenewswire.com
PFE | News A | $26.375 0.44% 1.9M

| -37.07% | O: 0.58% H: 0.24% C: -2.03%
BNTX | News | $89.07 1.2% 44K